The IMPT serves as the ‘communications and information hub’ for the field of multipurpose prevention technologies (MPTs).
Our resource center features a searchable database, providing you access to global MPT research, technical webinars, trainee and career resources, advocacy tools, and more. Search our resources!
Resource Search
Diversifying Funding Streams for MPT R&D
Demand for Novel Male Contraceptives & Requisite Need for Development of Male MPTs in Select LMICs
Male Contraceptive Initiative & IMPT: CT/MPT Fellowship Promotional Webinar
EECO Product Registration Toolkit
EECO Product Registration Toolkit August 2022 click to view Toolkit In this Technical Brief: Product Type(s): Drug Products Topic(s): Inactive Ingredients Region(s): United States
Sexually Transmitted Infections: Public Health Status and Opportunities for Multipurpose Prevention Technologies
Considerations when Transitioning an MPT Product Candidate from Preclinical to Clinical Development
Patenting and Intellectual Property Considerations for HIV Prevention & MPTs
Medicines Patent Pool: Licenses
Medicines Patent Pool: Licenses June 2022 click to view Webpage In this Technical Brief: Product Type(s): Long-Acting Therapeutics Topic(s): Licenses Region(s): United States, L/MICs
The Long-Acting Technologies Patents and Licenses Database
The Long-Acting Technologies Patents and Licenses Database June 2022 click to view Webpage In this Technical Brief: Product Type(s): Long-Acting Therapeutics Patents and Licenses Database Medicines Patent Pool Topic(s): Licenses Patents Long-Acting Technologies Region(s): United States, L/MICs
Integrating End-User Research in MPT Product Development & Commercialization Strategies
A Thought Paper on Fostering Greater Utilization of Social and Behavioural Research in The Development Setting and Creating Impact
Sexual Satisfaction Results With the Vaginal pH Modulator From the Phase 3 AMPOWER Study
MPT Regulatory Pathways: Case Studies From MPT Product Developers
Glossary of Regulatory Terms
Glossary of Regulatory Terms Feb 2022 click to view Guidance Document In this Technical Brief: Topic(s): Regulatory Terms Glossary Region(s): United States
Word on the Street: African Women Share Their Reproductive Health Stories
HIV prevention: better choice for better coverage
Inactive Ingredient Search for Approved Drug Products
Inactive Ingredient Search for Approved Drug Products January 2022 click to view Guidance Document In this Technical Brief: Product Type(s): Drug Products Topic(s): Inactive Ingredients Region(s): United States
Principles of Premarket Pathways for Combination Products
Principles of Premarket Pathways for Combination Products – Guidance for Industry and FDA Staff January 2022 click to view Guidance Document In this Technical Brief: Health Risk(s): Combination Products Product Type(s): Combination Topic(s): Regulatory Issues Region(s): United States
Medicines Patent Pool: Long-Acting Therapeutics
Medicines Patent Pool: Long-Acting Therapeutics December 2021 click to view Webpage In this Technical Brief: Product Type(s): Long-Acting Therapeutics Topic(s): Expanding Access to Long-acting Therapeutics in LMICs Region(s): United States, L/MICs
Multipurpose Prevention Technologies: Technology Landscape and Potential for Low- and Middle-Income Countries
Multipurpose Prevention Technologies: Technology Landscape and Potential for Low- and Middle-Income Countries View Report December, 2021 In this Report: Topic(s): Multipurpose Prevention Technology Pipeline Landscape
Introducing New Contraceptive Options: Product Registration Basics for Global Health Program Managers
Introducing New Contraceptive Options: Product Registration Basics for Global Health Program Managers In this Report: Topic(s): Regulatory Pathways Global Health Contraception
Advancing Self-Care with Multipurpose Prevention Technologies (MPTs)
Featured in the CTI Exchange’s Beginning with the End in Mind series, CAMI Health joins the nuanced conversation surrounding self-care within the sexual and reproductive health domain by highlighting the unique contributions and benefits of multipurpose prevention technologies (MPTs).
Can Fantasies Become Realities? The Quest for Multipurpose Prevention Products
Advances in long-acting injectables, implants, and vaginal rings for contraception and HIV prevention
Multipurpose Prevention Technologies: Opportunities and Challenges to Ensure Advancement of the Most Promising MPTs
Annual National Reproductive Health Conference
10-13 August 2021 Annual National Reproductive Health Conference San Francisco, CA, USA
Giving Voice to the End-User: Input on Multipurpose Prevention Technologies From the Perspectives of Young Women in Kenya and South Africa
MPT Mini Video Series
The IMPT introduces its MPT Mini Video Series, a new audiovisual project aimed to raise awareness about MPTs and bring digestible bits of the MPT story to your fingertips. The series kicks off with an introduction to the first-ever MPT in “King Minos & the First Condom.” In the second video, “If I Could Talk to the Scientists…”, we hear first-hand from health professionals at Wits RHI on the potential of MPTs to improve sexual and reproductive health. Stay tuned for upcoming videos in the series bringing you more voices from women around the world.
Compounds with Potential Activity to Prevent or Treat HIV and Other Sexually Transmitted Infections: A Landscape Review
Compounds with Potential Activity to Prevent or Treat HIV and Other Sexually Transmitted Infections: A Landscape Review July, 2021 click to view Report In this Report: Topic(s): Compounds with Multiple Potential Activities
Estimating the market size for a dual prevention pill: adding contraception to pre-exposure prophylaxis (PrEP) to increase uptake
Opportunities and Challenges for MPT & HIV Prevention Drug Delivery Approaches
New Frontiers in STI/HIV Prevention & Family Planning: The Promise of Multipurpose Prevention Technologies
Combining Active Pharmaceutical Ingredients: MPT Development & Regulatory Considerations
Microarray patches: Breaking down the barriers to contraceptive care and HIV prevention for women across the globe
Toxicity study considerations for HIV prevention and MPT R&D
MPTs & the IMPT Platform
MPTs & the IMPT Platform May 2021 The MPTs & the IMPT Platform is a PowerPoint presentation created by the IMPT Secretariat at CAMI Health to help our colleagues integrate MPTs into their talks and presentations. Please email IMPT@cami-health.org with any feedback on how you used this information. Download the presentation slide deck CAMI Health […]
Advocates’ Guide to Multipurpose Prevention Technologies
The Power of MPTs: Combining Prevention of HIV, other STIs, and Pregnancy
The Power of MPTs: Combining Prevention of HIV, other STIs, and Pregnancy The IMPT’s Susanna Moore, Bethany Young Holt, and IMPT Advisory Council Member Thesla Palanee-Philips of Wits Reproductive Health and HIV Institute (Wits RHI), University of the Witwatersrand, presented an introductory MPT panel at USAID’s Global Health Science and Practice Technical Exchange (GHTechX) in […]
Integrating Socio-behavioral & Market Research into MPT R&D: Applying Lessons Learned
TRIO Study Brief: Long-Acting Injections for Women’s HIV Prevention in Sub-Saharan Africa: What End-Users Think
Safety, acceptability, and pharmacokinetics of a monoclonal antibody-based vaginal multipurpose prevention film (MB66): A Phase I randomized trial
Microbicide Trials Network (MTN) Socio-behavioral Research Compendium
Multipurpose Prevention Technologies: Strategy recommendations to guide the most promising products from the lab to hands of women
Multipurpose Prevention Technologies: Strategy recommendations to guide the most promising products from the lab to hands of women January, 2021 Recent results from long-acting HIV prevention trials in parallel with the MPTs in the pipeline herald an exciting time for the MPT field. However, given finite resources and technical challenges to advance products from preclinical […]
The role of cervicovaginal microbiota on contraceptive and MPT development
Donation of Contraceptive Products through Special Import Permits: A Case Study in Zambia and Nigeria
Donation of Contraceptive Products through Special Import Permits: A Case Study in Zambia and Nigeria December 2020 click to view Guidance Document In this Technical Brief: Topic(s): Contraceptive Products Special Import Permits Region(s): Zambia Nigeria
HIV prevention is not all about HIV – using a discrete choice experiment among women to model how the uptake and effectiveness of HIV prevention products may also rely on pregnancy and STI protection
Use of International Standard ISO 10993-1, “Biological evaluation of medical devices – Part 1: Evaluation and testing within a risk management process”
Use of International Standard ISO 10993-1, “Biological evaluation of medical devices – Part 1: Evaluation and testing within a risk management process” September 2020 click to view Guidance Document In this Technical Brief: Product Type(s): Medical Devices Topic(s): Product Development Regulatory Issues Region(s): United States
MPT Trainee Photo Credit: Charmaine Cozzi, Wits RHI